14-CpG-Based Signature Improves the Prognosis Prediction of Hepatocellular Carcinoma Patients.
Hong-Ye JiangGang NingYen-Sheng WangWei-Biao LvPublished in: BioMed research international (2020)
The 14-CpG-based signature is significantly associated with OS and may be used as a novel prognostic biomarker for HCC patients.